Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT04745923
  4. Details
NCT04745923 Clinical Trial

Physical Activity Level in Patients With Chronic Kidney Disease During COVID-19 Pandemic

Covid19 Clinical Trial

Official title:
Fear of COVID-19 and Physical Activity Level in Patients With Chronic Kidney Disease During COVID-19 Pandemic

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04745923
Other study ID # GO 21/127
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 20, 2021
Est. completion date March 30, 2021

Study information
Verified date January 2021
Source Hacettepe University
Contact Merve Firat
Phone +903123051576
Email mervefirat@hacettepe.edu.tr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In the literature, there are no studies evaluating fear of COVID-19, anxiety, depression, physical activity, fear of movement and quality of life in patients with chronic kidney disease during COVID-19 pandemic. The investigators will evaluate these parameters in patients with chronic kidney disease and compare the findings of healthy individuals during COVID-19 pandemic

Recruitment information / eligibility
Status Recruiting
Enrollment 28
Est. completion date March 30, 2021
Est. primary completion date February 28, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Having been diagnosed with chronic kidney disease - Being clinically stable - Volunteering to participate in the research Exclusion Criteria: - Having a cognitive problem - Not being literate

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Turkey Hacettepe University, Faculty of Physical Therapy and Rehabilitation Ankara

Sponsors (1)
Lead Sponsor Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary Fear of COVID-19 COVID-19 phobia will be evaluated using Fear of COVID-19 Scale. 5 minutes
Primary Physical activity Physical activity level will be evaluated using International Physical Activity Questionnaire - Short Form (IPAQ-SF). 5 minutes
Secondary Qol Quality of life will be evaluated using SF-36 10 minutes
Secondary Anxiety and depression Anxiety and depression will be evaluated using Hospital Anxiety and Depression scale (HADS). 5 minutes
Secondary Fear of movement Fear of movement will be evaluated using the Tampa Scale for Kinesiophobia 10 minutes
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Active, not recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3